Dermanostic, a German company based in Düsseldorf, is facing an ongoing legal challenge over the risk classification of its teledermatology software platform from competitor company, Online Doctor 24 but has so far been successful in defending its case.
Dermanostic has classified its product as a low-risk class I device in the context of the Medical Device Regulation
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?